Journal of the National Cancer Institute Advance Access originally published online on April 8, 2008
JNCI Journal of the National Cancer Institute 2008 100(8):596-597; doi:10.1093/jnci/djn077
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Re: Breast Cancer Incidence, 1980–2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status
Affiliation of author: Cancer Surgery Sciences, Pasadena, CA
Correspondence to: David Z. J. Chu, MD, Cancer Surgery Sciences, 959 E. Walnut, #120, Pasadena, CA 91106 (e-mail: davidzjchu@yahoo.com).
| The first 10% of the full text of this article appears below. |
Glass et al. (1) recently reported an 18% decrease in rates of estrogen receptor–positive breast cancer